Frederick L. Hall
Impact in
- Oncology top 2%
- Cancer-related Molecular Pathways
- Cell Biology top 2%
- Microtubule and mitosis dynamics
Papers in
-
- Ubiquitin and proteasome pathways 13
- RNA Interference and Gene Delivery 7
- Oncology 41
- Cancer-related Molecular Pathways 26
- Co-authors
- Erlinda M. Gordon (47 shared papers)Philip R Vulliet (13 shared papers)Richard T. Williams (7 shared papers)Lingtao Wu (12 shared papers)D. A. Carbonaro-Hall (12 shared papers)W. French Anderson (11 shared papers)M Torres (1 shared paper)Kim L. O’Neill (1 shared paper)
- Journals
- Human Gene Therapy (9 papers)Journal of Biological Chemistry (8 papers)International Journal of Molecular Medicine (4 papers)Developmental Biology (3 papers)Proceedings of the National Academy of Sciences (3 papers)
- Partner nations
- United StatesSpainFrance
In The Last Decade
Frederick L. Hall
99 papers receiving 3.9k citations
Peers
Comparison fields: 5 of 115
- Oncology 1.1k
- Cell Biology 635
- Molecular Biology 2.5k
- Biotechnology 232
- Genetics 596
Countries citing papers authored by Frederick L. Hall
This map shows the geographic impact of Frederick L. Hall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frederick L. Hall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frederick L. Hall more than expected).
Fields of papers citing papers by Frederick L. Hall
This network shows the impact of papers produced by Frederick L. Hall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frederick L. Hall. The network helps show where Frederick L. Hall may publish in the future.
Co-authors
The 25 scholars most cited alongside Frederick L. Hall, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 104 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1994 | 227 | |
| 2 | 1992 | 198 | |
| 3 | 1993 | 182 | |
| 4 | 1992 | 164 | |
| 5 | 1993 | 164 | |
| 6 | 1988 | 155 | |
| 7 | 1989 | 144 | |
| 8 | 1993 | 128 | |
| 9 | 1999 | 106 | |
| 10 | Retroviral vector-mediated gene transfer of antisense cyclin G1 (CYCG1) inhibits proliferation of human osteogenic sarcoma cells. | 1995 | 90 |
| 11 | 1996 | 87 | |
| 12 | WAF1/Cip1 gene polymorphism and expression in carcinomas of the breast, ovary, and endometrium. | 1997 | 74 |
| 13 | Detection of a Cdc2-related kinase associated with Alzheimer paired helical filaments. | 1995 | 73 |
| 14 | 2004 | 70 | |
| 15 | 2018 | 69 | |
| 16 | 1991 | 61 | |
| 17 | 2009 | 60 | |
| 18 | 2009 | 60 | |
| 19 | 1998 | 56 | |
| 20 | 1991 | 56 |
About Frederick L. Hall
Frederick L. Hall is a scholar working on Molecular Biology, Oncology, Genetics, Cell Biology and Biotechnology, having authored 104 papers that have together received 4.0k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (26 papers), Virus-based gene therapy research (18 papers), Ubiquitin and proteasome pathways (13 papers), Cancer Research and Treatments (11 papers), Monoclonal and Polyclonal Antibodies Research (8 papers), RNA Interference and Gene Delivery (7 papers), Microtubule and mitosis dynamics (7 papers) and Neuroblastoma Research and Treatments (5 papers). The work is most often cited by research in Oncology (1.1k citations), Cell Biology (635 citations), Molecular Biology (2.5k citations), Biotechnology (232 citations) and Genetics (596 citations). Frederick L. Hall has collaborated with scholars based in United States, Spain and France. Frequent co-authors include Erlinda M. Gordon, Philip R Vulliet, Richard T. Williams, Lingtao Wu, D. A. Carbonaro-Hall, W. French Anderson, M Torres, Kim L. O’Neill, Jeffrey P. Mitchell and David Warburton. Their work appears in journals such as Human Gene Therapy, Journal of Biological Chemistry, International Journal of Molecular Medicine, Developmental Biology and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.